PQA 02 - Lung Cancer/Thoracic Malignancies, Patient Reported Outcomes/QoL/Survivorship, Pediatric Cancer

Presentations

• 04:45pm - 06:00pm PT

  2-Hydroxyisobutyrylation of ALDH1A3 Promotes Stemness Maintenance and Radiotherapy Resistance in NSCLC via Activation of the STAT3 Signaling Pathway

  Speaker: Zhiying Zhou, - Chongqing University, Chongqing
• 04:45pm - 06:00pm PT

  A Novel Imaging Biomarker for Radiation Induced Cardiotoxicity

  Speaker: Arezoo Modiri, PhD - University of Maryland School of Medicine, Baltimore, Baltimore
• 04:45pm - 06:00pm PT

  A Phase II Trial of Safety and Efficacy of Radiotherapy Combined with Anlotinib in Locally Advanced Non-Small Cell Lung Cancer Patients Intolerable to Concurrent Chemoradiotherapy: Preliminary Survival Analysis

  Speaker: Yupei Yuan, MD, MS - Cancer Hospital Chinese Academy of Medical Sciences, Beijing
• 04:45pm - 06:00pm PT

  A Pilot Study to Evaluate Percussive Ventilation Breath Hold to Improve Lung Stereotactic Ablative Radiotherapy (PVB-SABR)

  Speaker: Wilson Mai, MD, PhD - Stanford University Cancer Center, Stanford
• 04:45pm - 06:00pm PT

  A Prospective, Phase II, Single-Arm Trial Evaluating Efficacy and Safety of the Regimen of Induction Cadonilimab plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Cadonilimab Therapy for Unresectable Stage III NSCLC

  Speaker: Li CHU, - FUDAN UNIVERSITY SHANGHAI CANCER CENTER, SHANGHAI
• 04:45pm - 06:00pm PT

  A Prospective Study on the Predictive Value of the Modified Glasgow Prognostic Score in Non-Small Cell Lung Cancer Treated with Radiation Therapy

  Speaker: Zhe Chen, MD, PhD - University of Yamanashi, Chuo City
• 04:45pm - 06:00pm PT

  A Radiomics Method Based on Data Augmentation for Preoperative Prediction of Immature and Mature Teratoma

  Speaker: Jing Yang, - Department of Radiation Oncology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, P.R. China., Hangzhou
• 04:45pm - 06:00pm PT

  A Temporal Perspective: Charting and Predicting Treatment Response in Breast Cancer-Related Lymphedema

  Speaker: Enoch Yu, BS - Queen's University, Kingston
• 04:45pm - 06:00pm PT

  Advancing Adaptive Radiotherapy with High-Fidelity CBCT-Based In-Situ Dose Calculation

  Speaker: Scott Hollingsworth, BS - Washington University in St. Louis School of Medicine, St Louis
• 04:45pm - 06:00pm PT

  Analyzing Major Depressive Disorder Risk Factors and Survival in Elderly GI Cancer Patients Using the SEER-MHOS Database

  Speaker: Trudy Wu, MD, BS - University of California Los Angeles, Los Angeles
• 04:45pm - 06:00pm PT

  Arrythmias in Patients Receiving Thoracic Radiation

  Speaker: Holly Grace, MD - UT Southwestern Medical Center, Dallas
• 04:45pm - 06:00pm PT

  Assessing Construct Validity of ESAS in Minority Populations and Exploring Temporal Variations in PROs by HPV Status Using PCA

  Speaker: Shelly Sharma, MD - Baylor College of Medicine Hospital, Houston
• 04:45pm - 06:00pm PT

  Assessing Implementation of Electronic Patient-Reported Outcomes (ePRO) to Reduce Follow-Up Visits for Patients Undergoing Radiation Therapy for Breast Cancer

  Speaker: Marco Santos Teles, BS - Rutgers New Jersey Medical School, Newark
• 04:45pm - 06:00pm PT

  Assessment of Baseline Financial Toxicity and Associated Social Determinants of Health among a Diverse Patient Population Undergoing Radiation Treatment

  Speaker: Chaewon Hwang, MD - Tufts Medical Center | Beth Israel Deaconess Medical Center, Boston
• 04:45pm - 06:00pm PT

  Assessment of the Appropriateness of the Selection for Radiotherapy Intensity from a Quality of Life (EORTC QLQ-C30) Perspective in Older Cancer Patients

  Speaker: Shigehiko Kuribayashi, MD, PhD - Tokyo Women's Medical University, Tokyo 162-8666
• 04:45pm - 06:00pm PT

  Association between Geotemporal PM2.5 and Outcomes in Unresectable NSCLC Treated with Chemoradiotherapy

  Speaker: Ansel Nalin, MD, PhD - MD Anderson Cancer Center, Houston
• 04:45pm - 06:00pm PT

  Associations between Heart Rate Elevation, Tachycardia and Cardiac Substructure Dose in Patients Receiving Chemoradiotherapy for Non-Small Cell Lung Cancer (NSCLC)

  Speaker: Florence Keane, MD - Massachusetts General Hospital/ Harvard Medical School, Boston
• 04:45pm - 06:00pm PT

  Automated Radiation Response Assessment with Deep Learning and Radiomics in Pediatric Diffuse Midline Glioma

  Speaker: Reza Mojahed-Yazdi, MS - Harvard Medical School, Boston
• 04:45pm - 06:00pm PT

  Balancing Quality of Life Considerations and Efficacy of Stereotactic Body Radiotherapy in Patients with Interstitial Lung Disease

  Speaker: Simran Polce, MD - Moffitt Cancer Center, Tampa
• 04:45pm - 06:00pm PT

  Bayesian Model-Based Internal Target Volume Accounting for Interfractional Hilum Shifts during Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer

  Speaker: Kazuhito Ueki, MD, PhD - National Hospital Organization Kyoto Medical Center, Kyoto
• 04:45pm - 06:00pm PT

  Begin with the End in Mind: Assessing Symptom Index for Patients with Prostate Cancer to Select the Right Bladder Protocol for Radiotherapy

  Speaker: Omar Iskanderani, MD - King Abdulaziz University, Jeddah
• 04:45pm - 06:00pm PT

  Biology-Guided Radiotherapy for Lung and Bone Tumors: Early Insights into Local Control Outcomes from the Prospective Premier Registry

  Speaker: Tu Dan, MD - UTSW, Dallas
• 04:45pm - 06:00pm PT

  Biomarker Analysis of Iruplinalkib Combined with Chemoradiotherapy in ALK+ Unresectable Stage ? Non-Small Cell Lung Cancer

  Speaker: Linlin Wang, MD, PhD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 04:45pm - 06:00pm PT

  Bridging the Gap: Evaluating Patient Perceptions and Expectations of Radiation Therapy (PERT) Pre- and Post-Consultation

  Speaker: Ari Kassardjian, MD - City of Hope Comprehensive Cancer Center, Duarte
• 04:45pm - 06:00pm PT

  Can Simulation CTs be Used to Identify and Intervene on Incidental Coronary Artery Disease in Patients with Breast Cancer?

  Speaker: Kevin Chen, MD, MSCI - Washington University in St. Louis, St. Louis
• 04:45pm - 06:00pm PT

  Cardiac Risk, Outcomes, and Management among Older Adults with Stage I-II NSCLC Undergoing Stereotactic Body Radiation Therapy

  Speaker: Sanjana Shah, BS - Harvard Medical School, Boston
• 04:45pm - 06:00pm PT

  Cardiac Toxicity Following SBRT for Centrally Located Lung Tumors: Assessing the Impact of Radiation Dose Metrics

  Speaker: James Shen, MD, PhD - Yale Therapeutic Radiology, New Haven
• 04:45pm - 06:00pm PT

  Cardioprotective Medications and the Incidence of Cardiovascular Events in Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis

  Speaker: Vishwa Pakeerathan, MBBS - Princess Alexandra Hospital, Woolloongabba
• 04:45pm - 06:00pm PT

  Cardiovascular Outcomes Following Total Body Irradiation (TBI) in Children:A Systematic Review and Metanalysis

  Speaker: Aahan Arif, MBBS - St. Jude Children's Research Hospital, Memphis
• 04:45pm - 06:00pm PT

  Charlson Comorbidity Index as a Predictive Tool of Treatment Tolerance and Outcomes in Elderly Non-Small Cell Lung Cancer Patients Treated with Concurrent Proton or Photon Chemoradiation Followed by Immunotherapy

  Speaker: Cira Mollings Puentes, MD, BS - UT MD Anderson Cancer Center, Houston
• 04:45pm - 06:00pm PT

  Chemoradiotherapy Integrated Tumor Cell Microparticles Elicit Ferroptosis and Immune Remodeling in Malignant Pleural Effusion

  Speaker: Minqi Zhou, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan
• 04:45pm - 06:00pm PT

  Clinical and Dosimetric Predictors of Radiation Pneumonitis in Pathologic Stage III-N2 Non-Small Cell Lung Cancer Patients Receiving Postoperative Radiotherapy Following Lobectomy: An Analysis of a Prospective Cohort

  Speaker: Nengyang Wang, MD - Shanghai Chest Hospital Shanghai Jiao Tong University, Shanghai
• 04:45pm - 06:00pm PT

  Clinical and Pathological Characteristics of Exceptionally Young Patients with Multiple Primary Lung Cancers (ExY-MPLC) - Updated Data

  Speaker: Xiaomin Zhang, - Department of Radiation Oncology, Peking University Shenzhen Hospital,Shen Zhen,China, Guangdong
• 04:45pm - 06:00pm PT

  Clinical Efficacy and Adverse Effects of Radiotherapy in Pediatric Medulloblastoma with Residual or Disseminated Disease - A Single Center Experience

  Speaker: Xuejiao Shi, MD, PhD - Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, shanghai
• 04:45pm - 06:00pm PT

  Clinical Factors Associated with Urinary Morbidity in Men Undergoing Combination Prostate Radiation Therapy

  Speaker: Benjamin Lee, MD - Urology of Greater Atlanta, Stockbridge
• 04:45pm - 06:00pm PT

  Clinical Features and Treatment Outcomes of Pediatric Abdominal and Pelvic Rhabdomyosarcoma

  Speaker: Yuqing Wang, MD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing
• 04:45pm - 06:00pm PT

  Clinical Outcomes of Neoadjuvant Chemoimmunotherapy vs. Neoadjuvant Chemoradiotherapy in the Treatment of Operable Non-Small Cell Lung Cancer

  Speaker: Tal Sherman, MS, BS - Drexel University College of Medicine, Philadelphia
• 04:45pm - 06:00pm PT

  Clinical Outcomes of Stereotactic Body Radiation Therapy (SBRT) for Centrally and Ultracentrally Located Early-Stage Lung Cancer

  Speaker: Nikunj Patil, MD, MBBS - Kasturba Medical College, Manipal
• 04:45pm - 06:00pm PT

  Combining SBRT with GM-CSF and Peg-IFNa to Induce Abscopal Effects in Previously Treated Patients with Stage IV Thymic Tumors: A Prospective Study

  Speaker: Min Fan, MD, PhD - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai
• 04:45pm - 06:00pm PT

  Comparative Study of HEDOS and EDIC for Predicting 2-Year Survival in Locally Advanced NSCLC Patients Undergoing Radiotherapy

  Speaker: Alessandro Cicchetti, MD, PhD - Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan
• 04:45pm - 06:00pm PT

  Comparison of Changes in Pulmonary Function after SBRT vs. Surgery for Early-Stage Non-Small Cell Lung Cancer: A Prospective Real-World Observational Study

  Speaker: Yue Wang, Grad Student - Tianjin Medical University Cancer Institute and Hospital, Tianjin
• 04:45pm - 06:00pm PT

  Comparison of Scanning Beam Proton Therapy vs. Photon IMRT in Patients with Locally Advanced Non-Small Cell Lung Cancer

  Speaker: Model Zerfu, BS - University of Washington-Fred Hutchinson Cancer Center, Seattle
• 04:45pm - 06:00pm PT

  Comparison of the Efficacy of Immune Therapy Combined with Radiotherapy in Non-Gene-Sensitive Mutant NSCLC Brain Metastasis Patients: A Comparison of Whole-Brain Radiotherapy and Stereotactic Radiosurgery

  Speaker: Erha Munai, - School of Medicine, Chongqing University, Chongqing, China, Chongqing
• 04:45pm - 06:00pm PT

  Concurrent Immunotherapy Improves Progression-Free Survival but Increases Toxicity in Unresectable Stage III NSCLC

  Speaker: Dawei Chen, MD, PhD - Shandong Cancer Hospital and Institute, Shandong First Medical University, Jinan
• 04:45pm - 06:00pm PT

  Contemporary Experience with Percutaneous High Dose Rate (HDR) Brachyablation for Malignant Lung Tumors

  Speaker: Michelle Ann Eala, MD - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles
• 04:45pm - 06:00pm PT

  Cranial Radiotherapy Improves Survival in Brain Metastatic NSCLC Patients Bearing EGFR and TP53 Mutations

  Speaker: LU WANG, MD, PhD - Department of radiotherapy oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, chongqing
• 04:45pm - 06:00pm PT

  Daily vs. Every-Other-Day Stereotactic Body Radiotherapy for Treatment of Ultra-Central and Central Non-Small Cell Lung Cancer

  Speaker: Taylor Skelly, PharmD - University of Pittsburgh School of Medicine, Pittsburgh
• 04:45pm - 06:00pm PT

  Definitive Chemoradiation Therapy Followed by Immunotherapy (PACIFIC Regimen) in Stage III Large Cell Carcinoma: Assessing Efficacy Relative to Other Major Non-Small Cell Lung Cancer Subtypes

  Speaker: Chi Zhang, MD, PhD - Mayo Clinic Arizona, Phoenix
• 04:45pm - 06:00pm PT

  Delphi Consensus on Managing Non-Small Cell Lung Cancer (NSCLC) in Patients with Coexisting Interstitial Lung Disease

  Speaker: Alexander Louie, MD, PhD, MSc, FRCPC - Sunnybrook Health Sciences Centre, Toronto
• 04:45pm - 06:00pm PT

  Demographics, Disparities and Clinical Outcomes in Radiation Pneumonitis Hospitalizations with and without Lung Cancer: Retrospective Analysis of National Inpatient Sample (NIS)

  Speaker: Tijin Mathew, MD - Southeast Health, Dothan
• 04:45pm - 06:00pm PT

  Development and Validation of a Dynamic Nomogram for Predicting Brain Metastasis in Stage III NSCLC Patients Undergoing Definitive Chemoradiotherapy

  Speaker: Xianyan Chen, MD, PhD - West China Hospital of Sichuan University, Chengdu
• 04:45pm - 06:00pm PT

  Development of a Time-Weighted Technique to Improve the Accuracy of Amplitude-Based 4D-CT in Lung Cancer Radiotherapy

  Speaker: Jihyeon Joo, MD, PhD - Pusan National University School of Medicine, Yangsan
• 04:45pm - 06:00pm PT

  Do Patients with Head and Neck Cancer Feel Anxious about Mask Use during Radiotherapy? Importance of Medical Support and Coping Strategies

  Speaker: Rachida Laraichi, PhD - National Institute of Oncology, Rabat
• 04:45pm - 06:00pm PT

  Does Curative Radiotherapy Impact Fatigue Onset in Gynecological Cancer Patients? A 20-Year Single Institutional Experience in 501 Patients

  Speaker: Paolo Bonome, MD - Responsible Research Hospital, Campobasso
• 04:45pm - 06:00pm PT

  Domain-Specific Quality-of-Life Outcomes in GI Malignancies: A Comparative Analysis of SBRT, PBT and IMRT

  Speaker: Nikita Gupta, BS - Georgetown University School of Medicine, Washington
• 04:45pm - 06:00pm PT

  Dosimetric Evaluation of Radiotherapy Planning Optimization Based on Cardiac Subvolumes in Patients with Lung Cancer

  Speaker: H. Fazilet Dincbas, MD - Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Istanbul
• 04:45pm - 06:00pm PT

  Dosimetric Predictors of Pneumonitis in Unresectable Locally Advanced NSCLC: Impact of Chemoradiation with or without Immunotherapy

  Speaker: Ahmed Shalaby, MD - CINJ/RWJ, New Brunswick
• 04:45pm - 06:00pm PT

  Durvalumab Concurrent and Following Thoracic Radiotherapy vs. Concurrent Chemoradiotherapy and Consolidation Durvalumab in Locally Advanced Non-Small Cell Lung Cancer: A Propensity Matched Analysis of a Prospective Trial

  Speaker: Nikhil Mankuzhy, MD - Memorial Sloan Kettering Cancer Center, Middletown Township
• 04:45pm - 06:00pm PT

  Dynamic Change of Systemic Inflammatory Score in Predicting Survival of Patient with Unresectable Stage III Non-Small Cell Lung Cancer Treated by Definitive Chemoradiotherapy with or without Consolidate Immunotherapy: A Single-Arm, Retrospective Study

  Speaker: Shihong Luo, MD, MS - National Cancer Center CAMS & PUMC, Beijing
• 04:45pm - 06:00pm PT

  Effects of Liberalizing Lung V5 on Intermediate and High-Dose Exposure: Insights from Lung and Esophageal Cases Treated with Photons

  Speaker: Patrick Oh, MD - Yale School of Medicine, New Haven
• 04:45pm - 06:00pm PT

  Efficacy Analysis of Different Adjuvant Therapy Regimens in the Perioperative Period for Resectable Non-Small Cell Lung Cancer with Negative Driver Genes

  Speaker: Jiarui Zhao, MBBS - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan
• 04:45pm - 06:00pm PT

  Efficacy and Safety of Hypofractionated Radiotherapy Plus Sequential Chemotherapy with Immunotherapy in Patients with Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer

  Speaker: Yue Yu, - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing
• 04:45pm - 06:00pm PT

  Efficacy and Safety of Moderate-Dose SBRT for Patients with Oligometastatic Lung Cancer Ineligible for Standard SBRT

  Speaker: Jongmoo Park, MD, PhD - Kyungpook National University Chilgok Hospital, Daegu
• 04:45pm - 06:00pm PT

  Efficacy and Safety of Oral Chemotherapy Concurrent Radiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer after Neoadjuvant Chemoimmunotherapy

  Speaker: Lei Deng, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing
• 04:45pm - 06:00pm PT

  Efficacy and Safety of Thoracic Radiotherapy in Untreated Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma: A Multicenter Retrospective Analysis

  Speaker: Huiwen Yang, - Shandong Cancer Hospital, Jinan
• 04:45pm - 06:00pm PT

  Enhanced Survival in Stage IV NSCLC Patients: A Comparison of Sequential vs. Concurrent Radiotherapy Combined with Immunotherapy

  Speaker: Yuqi Wang, MD, RT - Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical-Sciences, Jinan
• 04:45pm - 06:00pm PT

  Enhancing Adverse Event Monitoring in Prostate Cancer Care with Large Language Models

  Speaker: Monique Shotande, PhD - Moffitt Cancer Center, Tampa
• 04:45pm - 06:00pm PT

  Esophageal Toxicity in Radical Radiotherapy Treatment of Malignant Pleural Mesothelioma

  Speaker: Alberto Revelant, MD - CRO AVIANO, Aviano
• 04:45pm - 06:00pm PT

  Evaluating Outcomes in NSCLC Patients Receiving Amivantamab and Intracranial Radiation

  Speaker: Nahid Howard, MS - Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona
• 04:45pm - 06:00pm PT

  Evaluating [¹⁸F]Fluorodeoxyglucose (FDG) Uptake as a Prognostic Metric in Stage IV Lung Cancer Patients Being Treated with Pharmacological Ascorbate and Chemotherapy

  Speaker: Ashley Way, MD - University of Iowa Hospitals & Clinics, Iowa City
• 04:45pm - 06:00pm PT

  Evaluating the Efficacy of Postoperative Radiotherapy in Thymoma Patients with Myasthenia Gravis

  Speaker: Rongrong Zhou, MD, DO, PhD, BSN - Xiangya Hospital, Changsha
• 04:45pm - 06:00pm PT

  Evaluation of Cumulative Doses to Organs at Risk during Lung Reirradiation

  Speaker: Navid Fallahi, MD - VCU Medical Center North Hospital - Massey Cancer Center, Richmond
• 04:45pm - 06:00pm PT

  Evaluation of Factors Affecting Radiological Changes and Treatment Response Following LUNG Stereotactic Ablative Radiotherapy

  Speaker: H. Fazilet Dincbas, MD - Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Istanbul
• 04:45pm - 06:00pm PT

  Evaluation of Physical Activity, Biological Rhythm, and Eating Behavior in Cancer Patients Receiving Radiation Therapy

  Speaker: Hatice Kubra Gunduz, MD - Marmara University Pendik Education and Research Hospital Radiation Oncology Clinic, Istanbul
• 04:45pm - 06:00pm PT

  Examining the Relationship between Cumulative Radiotherapy Dose to the Nipple-Areolar Complex and Breast Sensorisexual Function

  Speaker: Amarachi Okorom, BA - Icahn School of Medicine at Mount Sinai, Bronx
• 04:45pm - 06:00pm PT

  Examining Treatment and Outcome Disparities in Lung Cancer Among Northern Plains American Indians and Non-Indigenous Populations

  Speaker: Peter Wilson, MD - University of Minnesota, Minneapolis
• 04:45pm - 06:00pm PT

  Exploration on Perioperative Treatment Strategies of Driver Gene-Positive Resectable Non-Small Cell Lung Cancer

  Speaker: Xingpeng Wang, MD - School of Clinical Medicine, Shandong Second Medical University, Jinan
• 04:45pm - 06:00pm PT

  Exploratory Study on the Impact of Intestinal Low-Dose Radiation on the Efficacy and Prognosis of Immunotherapy in Metastatic Non-Small Cell Lung Cancer

  Speaker: Baiyang Huang, MS - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China, Jinan
• 04:45pm - 06:00pm PT

  Factors Associated with Prostate Cancer Survivors' Engagement in the Community, Results from a Population-Based Cohort

  Speaker: Shelby Watts, BS - University of Kansas Medical Center, Kansas City
• 04:45pm - 06:00pm PT

  FGFR3 Mediates Radioresistance in Non-Small Cell Lung Cancer through Reprogramming of Fatty Acid Metabolism

  Speaker: Ran Zhang, PhD - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan
• 04:45pm - 06:00pm PT

  Fifteen-Year Trends in Single-Fraction SBRT Utilization for Stage I Non-Small Cell Lung Cancer

  Speaker: Drew Moghanaki, MD, FASTRO, MPH - David Geffen School of Medicine at UCLA, Los Angeles
• 04:45pm - 06:00pm PT

  Financial Distress Does Not Increase after Radiation Therapy: Analysis of Change in COST Score before and after Radiation Therapy

  Speaker: Samyak Badkul, BS - Kansas Health Science Center, Wichita
• 04:45pm - 06:00pm PT

  Financial Stress and Cost-Coping Behaviors Associated with Financial Toxicity among a Diverse Patient Population Undergoing Radiation Treatment

  Speaker: Chaewon Hwang, MD - Tufts Medical Center | Beth Israel Deaconess Medical Center, Boston
• 04:45pm - 06:00pm PT

  Financial Toxicity in Patients with Sarcoma Undergoing Radiation Therapy

  Speaker: Rachel Zhang, BA - UCI School of Medicine, Orange
• 04:45pm - 06:00pm PT

  Functional Outcome Evaluation of Stereotactic Radiosurgery Treatment for Essential and Parkinsonian Tremor - A Private Institution Evaluation

  Speaker: Ann Pittier, MD - Tacoma/Valley Radiation Oncology, Tacoma
• 04:45pm - 06:00pm PT

  Genomic Predictors of Brain Metastases in Non-Small Cell Lung Cancer: Implications for Early Detection and Targeted Surveillance

  Speaker: Victor Lee, MD, BS - Yale New Haven Hospital, Middletown
• 04:45pm - 06:00pm PT

  Geriatric Assessment among Vulnerable Older Adults Undergoing Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

  Speaker: Leah Thompson, MD - Harvard Radiation Oncology Program, Boston
• 04:45pm - 06:00pm PT

  Harnessing Lactate-Efflux Inhibition to Sensitize Radiotherapy: A Metabolic-Immune Dual-Targeting Strategy for NSCLC

  Speaker: Wenqian Yuan, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan
• 04:45pm - 06:00pm PT

  High PD-L1 Expression is Associated with Adaptive Replanning in Patients with Locally Advanced (LA) Non-Small Cell Lung Carcinoma (NSCLC) Treated with Chemoradiotherapy (chemoRT)

  Speaker: Jennifer Zagelbaum, MD, PhD - Harvard Radiation Oncology Program, Boston
• 04:45pm - 06:00pm PT

  Higher Baseline Monocyte and Neutrophil Counts Are Associated with Significantly Worse Overall Survival in NSCLC Patients Treated with Curative-Intent Chemoradiation

  Speaker: Mathieu Gaudreault, PhD - Peter MacCallum Cancer Centre, Melbourne
• 04:45pm - 06:00pm PT

  High-Risk Carotid Artery Ultrasound Findings in Head and Neck Cancer Survivors after Radiation Therapy: Results of a Prospective Study

  Speaker: Ryan Hughes, MD - Wake Forest University School of Medicine, Winston Salem
• 04:45pm - 06:00pm PT

  Hyperfractionated Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer: A Retrospective Study

  Speaker: Wei Zhou, MD, BS - Chongqing Cancer Hospital, Chongqing
• 04:45pm - 06:00pm PT

  Hypofractionated Radiotherapy Sequenced with Immuno-Chemotherapy for Limited-Stage Small-Cell Lung Cancer

  Speaker: Kunpeng Xu, MD - National Cancer & Clinical Research Center/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen
• 04:45pm - 06:00pm PT

  Identification of Dosimetric and Clinical Predictors for Post-Treatment Pulmonary Hospitalizations in NSCLC

  Speaker: Josiah Nieto, MD - University of Michigan, Ann Arbor
• 04:45pm - 06:00pm PT

  Identification of Radioresistance Biomarkers Using Surface-Enhanced Raman Scattering (SERS) Molecular Diagnosis and Multi-Omics in NSCLC Cells

  Speaker: Nan Li, MD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, China, Chongqing
• 04:45pm - 06:00pm PT

  Imaging and Clinical Outcomes following Definitive Radiation Therapy for Children with High-Grade Glioma

  Speaker: Soumya Unnikrishnan, MD, MS - Winship Cancer Institute of Emory University, Atlanta
• 04:45pm - 06:00pm PT

  Impact of Cranial Proton Therapy on White Matter Development and Quality-of-Life in Pediatric Patients

  Speaker: Sang Hoon Seo, MD, PhD Candidate - Oncosoft, Seoul
• 04:45pm - 06:00pm PT

  Impact of Hepatic Radiotherapy on Survival Outcomes in Small Cell Lung Cancer Patients with Liver Metastases: A Retrospective Study

  Speaker: Xiangjiao Meng, PhD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 04:45pm - 06:00pm PT

  Impact of Household Income on Symptom Burden and Quality of Life in Long-Term Head and Neck Cancer Survivors

  Speaker: Reagan Andersen, BS - University of Alabama at Birmingham, Birmingham
• 04:45pm - 06:00pm PT

  Impact of Lung Dose on Pulmonary Function Decline after Stereotactic Body Radiation Therapy for Lung Cancer

  Speaker: Hidekazu Tanaka, MD, PhD - Yamaguchi University Graduate School of Medicine, Ube
• 04:45pm - 06:00pm PT

  Impact of PDL-1 Expression on Long Term Disease Outcomes in Unresectable Locally Advanced Non-Small-Cell Lung Cancer Treated with Chemoradiation with or without Immunotherapy

  Speaker: Charvi Shah, BS - Rutgers Robert Wood Johnson Medical School, New Brunswick
• 04:45pm - 06:00pm PT

  Impact of Prolonged Overall Treatment Time on Prognosis in Patients with Limited-Stage Small-Cell Lung Cancer Treated with Definitive Chemoradiotherapy

  Speaker: Miki Kajima, MD - Yamaguchi University Graduate School of Medicine, Ube
• 04:45pm - 06:00pm PT

  Impact of Radiation Therapy on Malignant Rhabdoid Tumor of the Kidney

  Speaker: David Gannon, MD - Vanderbilt University Medical Center, Nashville
• 04:45pm - 06:00pm PT

  Impact of Radiotherapy on Fatigue in Prostate Cancer Patients: An Analysis of 1253 Patients

  Speaker: Paolo Bonome, MD - Responsible Research Hospital, Campobasso
• 04:45pm - 06:00pm PT

  Impact of Radiotherapy Timing on Survival and Progression-Free Outcomes in Stage III-IV Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Retrospective Analysis

  Speaker: Fatma Yilmaz, MD - UPMC, Pittsburgh
• 04:45pm - 06:00pm PT

  Impact of Radiotherapy-to-Tyrosine Kinase Inhibitor Sequence and Time-Interval on Pneumonitis and Treatment Discontinuation in EGFR/ALK-Mutated Non-Small Cell Lung Cancer

  Speaker: Andrea Brown, MD - Johns Hopkins Radiation Oncology Kimmel Cancer Center, Baltimore
• 04:45pm - 06:00pm PT

  Impact of Smoking Status on Survival and Radiation-Induced Toxicity in Lung Cancer Patients Receiving Radiotherapy: A Retrospective Cohort Study

  Speaker: Daniel Przybysz, MD - RadioSerra Radiation Therapy, Rio de Janeiro
• 04:45pm - 06:00pm PT

  Impact of Socioeconomic Disadvantage on Quality of Life Changes at End of Radiotherapy

  Speaker: Koki Takabatake, MPH - Boston University School of Medicine, Arlington
• 04:45pm - 06:00pm PT

  Impact of Systematic Invasive Mediastinal Staging on Recurrence Rates Following SBRT for Early-Stage NSCLC

  Speaker: Rachel Fisher, MS - University of Arizona College of Medicine - Phoenix, Phoenix
• 04:45pm - 06:00pm PT

  Individual Participant Data Meta-Analysis (IPDMA) and Systematic Review of Radical Radiotherapy in Oligometastatic Non Small Cell Lung Carcinoma (NSCLC)

  Speaker: Ajay Kumar Kondeti, MD - All India Institute of Medical Sciences, Bibinagar, Hyderabad, Hyderabad
• 04:45pm - 06:00pm PT

  Induction Chemotherapy Administration Increases the Risk of Radiation Pneumonitis in Unresectable Stage III NSCLC Patients Undergoing Concurrent Chemoradiotherapy with Immunotherapy

  Speaker: Pengwei Li, MS - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 04:45pm - 06:00pm PT

  Induction Immunochemotherapy followed by Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer

  Speaker: Yaping Xu, PhD - Shanghai Pulmonary Hospital, Shanghai
• 04:45pm - 06:00pm PT

  In-Field Progression Rates Following Concurrent Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer: A Systematic Review

  Speaker: Shannon Nesbit, BS - David Geffen School of Medicine at UCLA, Los Angeles
• 04:45pm - 06:00pm PT

  Integrating Deep and Reinforcement Learning for Detection and Segmentation of Lung Metastases from Adenoid Cystic Carcinoma (ACC) in Chest CT Scans

  Speaker: Jin Sung Kim, PhD - Department of Radiation Oncology, Yonsei University College of Medicine, Seoul
• 04:45pm - 06:00pm PT

  Integration of Serum Metabolomics, MRI Radiomics, and Clinical Parameters for Predicting Long-Term Post-Radiotherapy Trismus in Nasopharyngeal Carcinoma: A Tri-Modal Modeling Approach

  Speaker: Lei Ji, MD - The First Affiliated Hospital of Soochow University, Soochow
• 04:45pm - 06:00pm PT

  Intentional Protection of the Contralateral Esophagus in Thoracic Radiotherapy for Lung Cancer

  Speaker: Jia-Qi Huang, - Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai
• 04:45pm - 06:00pm PT

  Investigation of the 'New-PDL1' Delta Radiomic Signature for Identifying Chemo-Radiotherapy Patients Who May Benefit from Consolidation Immunotherapy

  Speaker: Andrea Filippi, MD - Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan
• 04:45pm - 06:00pm PT

  Irradiation-Induced CK2/SUPT16H Axis Modulation Enhances Radiation Resistance in Lung Cancer via DNA Damage Response and Chromatin Remodeling

  Speaker: Rui Meng, PhD - Department of Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
• 04:45pm - 06:00pm PT

  KEAP1/NRF2 Mutation Phenotype Predicts Local Control in Early-Stage Lung Cancer Patients Treated with Stereotactic Ablative Radiotherapy

  Speaker: Noah Kastelowitz, MD, PhD - Stanford University School of Medicine, Stanford
• 04:45pm - 06:00pm PT

  Knockdown of AKR1C1 Enhances NEDD4-Mediated Ubiquitination of GPX4 to Promote Ferroptosis and Radiosensitization in Non-Small Cell Lung Cancer

  Speaker: Weiwei Yan, - Shandong Cancer Hospital Affiliated to Shandong University, Jinan
• 04:45pm - 06:00pm PT

  Leveraging Nanomechanical Signatures as Predictive Biomarkers for Radiation Therapy Guidance in Advanced Solid Tumors

  Speaker: James Welsh, MD - Professor, Houston
• 04:45pm - 06:00pm PT

  LncRNA SNHG17/IGF2BP1/AURKA Axis Promotes Radiation Resistance in Non Small-Cell Lung Cancer by Regulating Autophagy

  Speaker: Fengti Chen, - Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, Nanning
• 04:45pm - 06:00pm PT

  Long-Term Survival and Undetectable Circulating Tumor DNA Following Comprehensive Involved Site Radiotherapy for Oligometastases

  Speaker: Megha Schmalzle, BS - New York Institute of Technology College of Osteopathic Medicine, Old Westbury
• 04:45pm - 06:00pm PT

  Low-Dose Radiotherapy Enhances the Antitumor Immunity of ISABR in Non-Small Cell Lung Cancer

  Speaker: Ziye Li, MD - First Affiliated Hospital of University of Science and Technology of China, Hefei
• 04:45pm - 06:00pm PT

  Lung V5 and Post-Radiation Lymphopenia as Predictors of Symptomatic Radiation Pneumonitis in Real-World Lung Cancer Patients in China: A Retrospective Analysis

  Speaker: Qianqian Lei, MD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing
• 04:45pm - 06:00pm PT

  Magnetic Resonance can be Used in Guiding Hypo-Fractionated Radiotherapy for Non-Small Cell Lung Cancer

  Speaker: Ligang Xing, MD, RT - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China, Jinan
• 04:45pm - 06:00pm PT

  MGLL-Driven Ferroptosis via ATG9A-Mediated Lipid Mobilization Enhances Radiosensitivity in NSCLC

  Speaker: Yujiao Ma, MS - Shandong university, Jinan
• 04:45pm - 06:00pm PT

  Molecular Markers in Lung Cancer as a Predictor of Response to SBRT

  Speaker: Rakhi Kaila, MD - Detroit Medical Center, Detroit
• 04:45pm - 06:00pm PT

  Monocyte-Macrophage Modulation in Radiation-Immunotherapy-Induced Pneumonitis in NSCLC

  Speaker: Qian Zhao, MD, PhD - Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 04:45pm - 06:00pm PT

  MR vs. CT-Based Cardiac Delineation in Pediatric Patients with Hodgkin Lymphoma

  Speaker: Sidharth Ramesh, MD - Hospital of the University of Pennsylvania, Philadelphia
• 04:45pm - 06:00pm PT

  MTA3-Driven Glutamine Synthetase Upregulation as a Mechanism for Radiosensitivity Regulation in Non-Small Cell Lung Cancer

  Speaker: Liang Du, PhD - Chongqing University Cancer Hospital, Chongqing
• 04:45pm - 06:00pm PT

  Multidisciplinary Team (MDT) Perceptions toward the Treatment of Limited-Stage Small-Cell Lung Cancer (LS-SCLC): A U.S. Physician Survey

  Speaker: Rebeca Mora, MD - AstraZeneca, gaithersburg
• 04:45pm - 06:00pm PT

  Neuroanatomical Structural Changes in Irradiated Survivors of Craniopharyngioma: A Secondary Analysis of RT3CR

  Speaker: Aahan Arif, MBBS - St. Jude Children's Research Hospital, Memphis
• 04:45pm - 06:00pm PT

  Nutrition-Related Hematological and Body Composition Biomarkers in Stage III Unresectable NSCLC Treated with Immunochemoradiotherapy: A Retrospective Cohort Study

  Speaker: Xia Gan, MBBS - Hunan Cancer Hospital, Changsha
• 04:45pm - 06:00pm PT

  Off-Protocol Radiotherapy in Prospective Systemic Therapy Trials for Metastatic Non-Small Cell Lung Cancer

  Speaker: Kara Ruicci, MD, PhD - University of Toronto, Toronto
• 04:45pm - 06:00pm PT

  OIP5 Mediates Radiotherapy Resistance in Lung Adenocarcinoma through POLD1-Dependent DNA Damage Repair

  Speaker: Siwei Zeng, - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing
• 04:45pm - 06:00pm PT

  Optimizing Chemoradiotherapy for Small Cell Lung Cancer in the Immunotherapy Era

  Speaker: Travis Lambert, MD - Montefiore Medical Center/Albert Einstein College of Medicine, Bronx
• 04:45pm - 06:00pm PT

  Optimizing Fractionation Strategies for Early-Stage NSCLC: Real-World Toxicity and Outcomes from a Statewide Consortium

  Speaker: Luke Higgins, MD - University of Michigan, Ann Arbor
• 04:45pm - 06:00pm PT

  Outcomes and Toxicity of 60 Gy in 8 Fractions Stereotactic Body Radiotherapy to Peripheral Tumors Adjacent to the Chest Wall: A Single Institution Experience

  Speaker: Tala Mobayed, MD - American University of Beirut Medical Center, Beirut
• 04:45pm - 06:00pm PT

  Outcomes and Treatment Patterns in Pediatric Head and Neck Rhabdomyosarcoma: A Retrospective Study of 105 Patients

  Speaker: Mohammed Qamber, MD - Bahrain Oncology Center, Muharraq
• 04:45pm - 06:00pm PT

  Outcomes Following Proton Radiation for Pediatric Meningiomas

  Speaker: Elizabeth Thompson, MD, BS - University of Florida, Gainesville
• 04:45pm - 06:00pm PT

  Outcomes of Patients with Intracranial Germinoma Enrolled on the Pediatric Proton Photon Consortium Registry

  Speaker: Elaine Cha, MD - MD Anderson Cancer Center, Houston
• 04:45pm - 06:00pm PT

  Outcomes of Single-Fraction Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: A Multi-Institution Population-Based Study

  Speaker: Jose Miguel Callueng, MD - BC Cancer Agency - Kelowna, Muntinlupa City
• 04:45pm - 06:00pm PT

  Patient Reported Outcomes (PROs) after Radiation Therapy or Surgery followed by Radiation Therapy for Prostate Cancer

  Speaker: Muhammad Shuja, MD - Mayo Clinic, Rochester
• 04:45pm - 06:00pm PT

  Patient-Reported Outcomes (PROs) in Prostate Cancer Patients Undergoing IMRT vs. IMRT with Brachytherapy

  Speaker: Emily Hanus, BS - University of Kansas School of Medicine, Kansas City
• 04:45pm - 06:00pm PT

  Patterns of Failure and Toxicity in Patients with N2 vs. N3 Disease Undergoing Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer

  Speaker: Melanie Berger, MD - Hospital of the University of Pennsylvania, Philadelphia
• 04:45pm - 06:00pm PT

  Patterns of Failure for Patients with Thymoma Treated with Post Operative Radiation Therapy

  Speaker: Oded Icht, MD, MBA - Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto
• 04:45pm - 06:00pm PT

  Phenotyping Chronological Accumulation of Comorbidities for Prostate Cancer Patients: A Computational Approach

  Speaker: Matthew Kim, BS - University of California, San Francisco, San Francisco
• 04:45pm - 06:00pm PT

  PIK3CD Affect Radiotherapy Resistance in LUAD Cells by Reprogramming Lipid Metabolism through PI3K/AKT Pathway

  Speaker: Yingze Ma, MB, MBBS - Shandong Cancer Hospital and Institute, Jinan
• 04:45pm - 06:00pm PT

  Portrayal of Radiation Therapy in North American TV Shows

  Speaker: Elsa Sutton, MD - Mayo Clinic Rochester, Rochester
• 04:45pm - 06:00pm PT

  Post Radiotherapy Lymphocyte Dynamics and Dose Constraints in Locally Advanced Thoracic Malignancies Undergoing Radical Radiotherapy

  Speaker: Ben Man Fei Cheung, MD - Queen Mary Hospital, Hong Kong
• 04:45pm - 06:00pm PT

  Postmarketing Surveillance of Adverse Events after Immune Checkpoint Inhibitor Therapy and Radiotherapy

  Speaker: Qian Zhang, MD, PhD, MS - McGaw Medical Center of Northwestern University, Chicago
• 04:45pm - 06:00pm PT

  Postoperative Radiotherapy in Surgically Resected Pathologic N2 Non-Small Cell Lung Cancer Post-Chemotherapy: A Multicenter Study

  Speaker: Zeliang Ma, MD - Mayo Clinic Rochester, Rochester
• 04:45pm - 06:00pm PT

  Practice Variations and Outcomes of Definitive Radiation for Non-Metastatic NSCLC following Induction Chemoimmunotherapy

  Speaker: Troy Kleber, MD, MS - MD Anderson Cancer Center, Houston
• 04:45pm - 06:00pm PT

  Predicting Decreased Quality of Life in Cancer Survivors Undergoing Radiotherapy Using a Random Forest Model

  Speaker: Meimei Shang, - Shandong Cancer Hospital and Institute, Shandong First University, Jinan
• 04:45pm - 06:00pm PT

  Prediction of Esophagitis following Intensity-Modulated Radiotherapy for Lung Cancer Using Statistical and Machine Learning Methods

  Speaker: Nathaniel Miller, MD - Virginia Commonwealth University, Richmond
• 04:45pm - 06:00pm PT

  Prediction of Oligometastatic Disease from Breast Cancer Using Next Generation Sequencing Genomics

  Speaker: Patrick Young, DO - Atrium Health Wake Forest Baptist, Winston-Salem
• 04:45pm - 06:00pm PT

  Predictive Risk Factors for Radiation Retinopathy in Eye Brachytherapy

  Speaker: Zhibin Huang, PhD - Vitruvian Health, Murfreesboro
• 04:45pm - 06:00pm PT

  Preparation of mRNA-LNP Vaccine Based on HER2 Target and Its Antitumor Effect in Combination with Radiotherapy in Lung Cancer

  Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang
• 04:45pm - 06:00pm PT

  Primary Lesion-Directed Stereotactic Body Radiotherapy for Advanced Non-Small Cell Lung Cancer Treated with First-Line Systemic Therapy

  Speaker: Dan Tao, MD - Chongqing University Cancer Hospital, Chongqing
• 04:45pm - 06:00pm PT

  Prognostic Value and Immunological Correlation of Spleen Volume Change in Extensive-Stage Small-Cell Lung Cancer Treated with Chemo-Immunotherapy

  Speaker: Xiuli Liu, MS - Department of Radiation Oncology, Shandong Cancer Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China, Jinan
• 04:45pm - 06:00pm PT

  Promise of LET-Optimized Intensity Modulated and Arc Proton Therapy for Pediatric Rhabdomyosarcoma: A Multi-Patient Comparative Dosimetry Study

  Speaker: Daniel Indelicato, MD, FASTRO - University of Florida Department of Radiation Oncology, Jacksonville
• 04:45pm - 06:00pm PT

  Prophylactic Cranial Irradiation in Resected Early Stage Small Cell Lung Cancer: An Updated Systematic Review and Meta-Analysis

  Speaker: Ze Yuan, MD - Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing
• 04:45pm - 06:00pm PT

  Prospective, Longitudinal Assessment of Financial Toxicity and Emotional Well-Being for Women with Gynecologic Cancers Receiving Radiotherapy

  Speaker: Michayla Brown, MS - University of Alabama at Birmingham, Birmingham
• 04:45pm - 06:00pm PT

  Prospective Patient-Reported Outcomes (PRO) Regarding Skin Toxicity from Hypo-Fractionated Regional Nodal Irradiation (RNI) following Mastectomy and Lumpectomy

  Speaker: Sunitha Varghese, MD, MBBS - The University of Kansas Health System, Kansas city
• 04:45pm - 06:00pm PT

  Prospective Validation of a Pretreatment 18F FDG PET CT plus Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Consolidation Immunotherapy

  Speaker: Joseph Deasy, PhD - Memorial Sloan Kettering Cancer Center, New York
• 04:45pm - 06:00pm PT

  Proton Therapy for Hemithoracic Pleural Irradiation: A Step Toward Safer Radiation Treatment

  Speaker: Drishti Panse, MD, BS - Icahn School of Medicine at Mount Sinai, New York
• 04:45pm - 06:00pm PT

  Proton Therapy for Pediatric Patients with Localized Unresectable Osteosarcoma

  Speaker: Daniel Indelicato, MD, FASTRO - University of Florida Department of Radiation Oncology, Jacksonville
• 04:45pm - 06:00pm PT

  Proton Therapy in Pediatric Craniopharyngioma: Comparison between Adjuvant and Salvage Radiotherapy Efficacy and Toxicity

  Speaker: Ory Haisraely, MD, MPH - MD Anderson Cancer Center, Houston
• 04:45pm - 06:00pm PT

  Quality-of-Life Metrics Correlate with Dual-Energy and 4D CT Derived Perfusion and Ventilation in Lung Cancer Patients 6 Months Post Radiation Therapy

  Speaker: Maksym Sharma, PhD - University of Pennsylvania, Philadelphia
• 04:45pm - 06:00pm PT

  Quantifying Radiation-Induced Pulmonary Fibrosis: A Novel CT-Based Approach to Measuring Lung Scarring after SBRT

  Speaker: Asif Harsolia, MD - Memorial Radiation Oncology Medical Group, Fountain Valley
• 04:45pm - 06:00pm PT

  Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science

  Speaker: David Kozono, MD, PhD - Dana-Farber Brigham Cancer Center, Boston
• 04:45pm - 06:00pm PT

  Radiomics Analysis in SBRT for Pulmonary Oligometastases: The Potential of Peritumoral Features in Predicting Treatment Response

  Speaker: Yao Lu, MS - The First affiliated Hospital Zhejiang University School of Medicine, Hangzhou
• 04:45pm - 06:00pm PT

  Radiosurgery for Pediatric Central Nervous System Lesions - Initial Report and Insights from a Multicenter Registry

  Speaker: Felix Ehret, MD - Massachusetts General Hospital, Boston
• 04:45pm - 06:00pm PT

  Randomization in Oligoprogressive Disease: Can We Still Run Trials, or Have We Lost Equipoise?

  Speaker: Houda Bahig, MD, PhD - Centre Hospitalier de l'Universite de Montreal, Montreal
• 04:45pm - 06:00pm PT

  Rates of Fertility/Hormonal Preservation among Locally Advanced Cervical Cancer Patients Treated with Definitive Chemoradiation and Brachytherapy

  Speaker: Stella Lymberis, MD - New York University Langone Medical Center, New York
• 04:45pm - 06:00pm PT

  Real World Radiographic Response Rates and Pre-Operative Attrition in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Neoadjuvant Chemoimmunotherapy

  Speaker: Cole Friedes, MD - University of Pennsylvania, Philadelphia
• 04:45pm - 06:00pm PT

  Real-World Data of Radiotherapy Induced Hypothyroidism in Head and Neck Cancer Patients

  Speaker: Hao-Shen Cheng, MD - Taichung Veterans General Hospital, Taichung
• 04:45pm - 06:00pm PT

  Real-World Outcomes of Single-Fraction Stereotactic Ablative Radiotherapy (SF-SABR) for Oligo-Persistent, Progressive, or Recurrent Primary and Metastatic Lung Tumors

  Speaker: Wei-chieh Huang, MD - National Taiwan University Hospital, Taipei
• 04:45pm - 06:00pm PT

  Real-World Study on the Efficacy, Safety, and Prognostic Analysis of Chemotherapy Combined with Immunotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer

  Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang
• 04:45pm - 06:00pm PT

  Refining SBRT for Ultra-Central NSCLC: Non-Uniform PTV and Strict OAR Constraints for Optimal Control and Minimal Toxicity

  Speaker: Yaping Xu, PhD - Shanghai Pulmonary Hospital, Shanghai
• 04:45pm - 06:00pm PT

  Reirradiation for Pediatric Central Nervous System Tumors: Validation of an LQ Model-Based Approach for Critical Structure Dose Constraints and Clinical Outcomes

  Speaker: Natalia Martynova, MD - Dr. Berezin Medical Institute, Saint-Petersburg
• 04:45pm - 06:00pm PT

  Reirradiation or Repeat Organ Irradiation for Non-Small Cell Lung Cancer: Oncological Outcomes and Toxicities

  Speaker: Jonas Willmann, MD - University Hospital Zurich, Kilchberg
• 04:45pm - 06:00pm PT

  Representativeness and Generalizability of NCI-Funded Multi-Modality Randomized Clinical Trials (RCTs): A Case Study of Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Based on RTOG-0617 and the National Cancer Database (NCDB)

  Speaker: Cecilia de Sousa, MD, MPH - Johns Hopkins Medicine, Baltimore
• 04:45pm - 06:00pm PT

  Retrospective Study of the Efficacy and Safety of Lung Malignancy Radiation In-Field of Prior Ipsilateral Breast Radiation

  Speaker: Mary-Kate Lawlor, MD - Yale New Haven Health, New Haven
• 04:45pm - 06:00pm PT

  Risk of Cardiac Toxicity Influences Treatment Decisions in Lung Cancer: A National Survey

  Speaker: Erik Blomain, MD, PhD - Thomas Jefferson University, Philadelphia
• 04:45pm - 06:00pm PT

  Role of Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer Patients with Bone Metastases: A Multicenter Retrospective Analysis

  Speaker: Xinyu Fan, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 04:45pm - 06:00pm PT

  Safety and Activity of KRAS G12C Inhibitors Combined with Thoracic Radiation Therapy

  Speaker: Helen Zhang, MD - Memorial Sloan Kettering Cancer Center, New York
• 04:45pm - 06:00pm PT

  Safety and Efficacy of Lung Stereotactic Body Radiation Therapy for Surgical Staple Line Recurrences

  Speaker: Katie Scharf, MD - Rush University Medical Center, Chicago
• 04:45pm - 06:00pm PT

  Safety and Efficacy of Photon Re-Irradiation with Whole Brain Radiotherapy or Craniospinal Irradiation for Recurrent Pediatric Central Nervous System Malignancies

  Speaker: Palak Patel, MD - Massachusetts General Brigham, Boston
• 04:45pm - 06:00pm PT

  Salvage Proton Therapy after Primary Cryosurgery or HIFU for Prostate Cancer

  Speaker: Daniel Lichlyter, BS - University of Florida College of Medicine, Department of Radiation Oncology, Gainesville
• 04:45pm - 06:00pm PT

  Screening of the Population Benefiting from Postoperative Radiotherapy in Resectable Stage III-N2 NSCLC Patients Receiving Neoadjuvant Chemoimmunotherapy

  Speaker: Min Li, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 04:45pm - 06:00pm PT

  Secondary Imaging Analysis of a Clinical Trial Combining SABR and PEF Ablation for Central Lung Tumors

  Speaker: Nicholas Peterson, MD - University of California, Irvine, Orange
• 04:45pm - 06:00pm PT

  Sexual Toxicity after Chemoradiation for Anal Cancer among Men who have Sex with Men

  Speaker: Beck Gold, BS - George Washington University School of Medicine, Washington
• 04:45pm - 06:00pm PT

  Should We Return to Old School in a New Era? A Meta-Analysis of Twice Daily vs. Once Daily Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer

  Speaker: Bin Gui, MD, MS - Northwell Health, Lake Success
• 04:45pm - 06:00pm PT

  Single-Cell Atlas and Mechanistic Study of Lung Adenocarcinoma with Pulmonary Sarcomatoid Carcinoma

  Speaker: Yuequn Ma, PhD - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 04:45pm - 06:00pm PT

  Single-Fraction Lung SBRT for Primary and Metastatic Lung Tumors: Ten-Year Experience

  Speaker: Luis Larrea, MD, PhD - Hospital Vithas Valencia Consuelo, Valencia
• 04:45pm - 06:00pm PT

  Site-Specific Associations between NCCN Distress Thermometer Screening Data and NLP-Identified Toxicities during Radiotherapy

  Speaker: Michelle Zhao, BA - UCSF, San Francisco
• 04:45pm - 06:00pm PT

  Sociodemographic and Molecular Determinants of Disparities in NSCLC Outcomes: A Multi-Institutional Genomic Analysis

  Speaker: Cesar Marquez, MD, PhD - MD Anderson Cancer Center, Houston
• 04:45pm - 06:00pm PT

  Sociodemographic Factors Associated with Proton Therapy Accessibility in NRG Oncology Trials of Locally Advanced NSCLC

  Speaker: Bryan Johnson, MD, MBA - Mayo Clinic Florida, Jacksonville
• 04:45pm - 06:00pm PT

  Sparing Secondary Lymphoid Organs Significantly Reduces Immune Suppression and Improves OS during Lung SBRT: Secondary Analysis of a Randomized, Phase 2 Trial

  Speaker: Verny Rodriguez, MD - University of Kentucky, Lexington
• 04:45pm - 06:00pm PT

  Stereotactic Body Radiotherapy for the Treatment of Oligometastases Located in the Peritoneum or in the Abdominal Wall: Preliminary Results from a Mono-Institutional Analysis

  Speaker: Francesco Cuccia, MD - ARNAS - Civico Hospital, Palermo
• 04:45pm - 06:00pm PT

  Stereotactic Radiosurgery for Recurrent Primary and Metastatic CNS Malignancies in the Pediatric Population

  Speaker: Michael Gribble, MD - UCSF Radiation Oncology, San Francisco
• 04:45pm - 06:00pm PT

  Stiff Matrix Promotes Radioresistance in Lung Cancer via the Rho/ROCK-YAP/TEAD4 Signaling Axis

  Speaker: Meng Yuan, MD - None, Beijing
• 04:45pm - 06:00pm PT

  Study on the Mechanism of ATF3 in Regulating Radiation-Induced Lung Injury

  Speaker: Yang Liu, RT - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, jinan
• 04:45pm - 06:00pm PT

  Survival Disparities in Lung Cancer Based on Tumor Staging and Demographics in a Third World Country Radiation Therapy Cohort

  Speaker: Daniel Przybysz, MD - RadioSerra Radiation Therapy, Rio de Janeiro
• 04:45pm - 06:00pm PT

  Targeting ADAM17 N-glycosylation Enhances Radiosensitivity in Non-Small Cell Lung Cancer via the NOTCH-ABCC1-ROS/cGAMP axis

  Speaker: Ran Zhang, PhD - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan
• 04:45pm - 06:00pm PT

  Targeting Educational Needs and Patient Reported Outcomes in Spanish-Speaking Latino/a Radiation Oncology Patients

  Speaker: Oscar Padilla, MD - Mount Sinai Hospital, New York
• 04:45pm - 06:00pm PT

  Targeting Protein Kinase CK2 to Reprogram Phospholipid Metabolism and Enhance the Efficacy of Radioimmunotherapy in Lung Cancer

  Speaker: Rui Meng, PhD - Department of Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
• 04:45pm - 06:00pm PT

  The Changing Dogma in Oligometastatic Renal Cell Carcinoma - SBRT

  Speaker: Papaiah Susheela Sridhar, MD, DNB - Apollo Cancer centre,Bangalore, Bangalore
• 04:45pm - 06:00pm PT

  The Effect of Adding Consolidation Durvalumab to Hypofractionated Involved-Field Radiotherapy with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: Does Durvalumab Consolidation Therapy Bring Survival Benefits?

  Speaker: Tsubasa Kameoka, MD - Miyoshi central hospital, Miyoshi
• 04:45pm - 06:00pm PT

  The Impact of Effective Dose to Immune Cells and Platelet-to-Lymphocyte Ratio on Lymphopenia and Prognosis in Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer

  Speaker: Haoting Yang, MD - Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 04:45pm - 06:00pm PT

  The Results of Re-Irradiation in Pediatric Recurrent Central Nervous System Tumors

  Speaker: Ayca Iribas, MD - Istanbul University, Istanbul
• 04:45pm - 06:00pm PT

  The Role of Radiotherapy in Unresectable Primary Pulmonary Sarcoma: A Multicenter Study

  Speaker: Ailing Liu, MD - Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 04:45pm - 06:00pm PT

  Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer with Liver Metastases: A Multicenter Retrospective Evaluation of Survival Outcomes

  Speaker: Xinyu Fan, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 04:45pm - 06:00pm PT

  Too Full to Fail? Impact of Excessive Bladder Filling on Patient Experience in Prostate Cancer Radiotherapy

  Speaker: Luke Peng, MD, MS - Brigham and Women's/Dana Farber Cancer Institute, Boston
• 04:45pm - 06:00pm PT

  Topical Honeysuckle Flower Gel for Radiation Dermatitis: A Novel Approach to Prevention and Management

  Speaker: Chin-Nan Chu, MD, PhD - Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan, R.O.C., Taichung
• 04:45pm - 06:00pm PT

  Toxicities of Brain and Spinal Cord Photon and Proton Radiation in Pediatric Brain Tumors Assessed by Real-World Data (RWD)

  Speaker: Brandon Craig, MD, PhD - University of Calgary, Calgary
• 04:45pm - 06:00pm PT

  Toxicity and Quality of Life (QOL) Outcomes of Short Course Radiotherapy (SCRT) by Intensity Modulated Radiotherapy (IMRT) in Rectal Cancer - Institutional Prospective Database

  Speaker: Trinanjan Basu, MD - HCG Cancer Center, Mumbai
• 04:45pm - 06:00pm PT

  Toxicity Profile for Connective Tissue Disease Patients Treated with Lung Stereotactic Body Radiation Therapy (SBRT)

  Speaker: Adannia Ufondu, MD, BA - Cleveland Clinic, Cleveland
• 04:45pm - 06:00pm PT

  Transgender and Non-Binary Disparities: Discrimination Impact on Health-Related Quality of Life - All of Us Cancer Survivor Study

  Speaker: Daniel Sabater Minarim, MS - UCSD Health, La Jolla
• 04:45pm - 06:00pm PT

  Treatment Approach in Childhood Ewing Sarcoma - TROD Hematology Oncology Pediatric Oncology Total Body Irradiation Working Group Survey Study

  Speaker: Candan Demiroz, MD, RT - Bursa Uludag University Faculty of Medicine, Bursa
• 04:45pm - 06:00pm PT

  Treatment Interruptions in NSCLC Radiotherapy: Impact on Outcomes in a Statewide Quality Collaborative

  Speaker: Ameer Elaimy, MD, PhD, BS - University of Michigan Health System, Ann Arbor
• 04:45pm - 06:00pm PT

  Treatment Outcomes of High-Dose Hypofractionated Palliative Radiotherapy (40 Gy in 10 daily fractions) for Non-Small Cell Lung Cancer

  Speaker: James Chow, MBChB - Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon
• 04:45pm - 06:00pm PT

  Treatment Strategy for Potentially Resectable Stage III-N2 Driver Gene-Negative NSCLC in the Immunotherapy Era

  Speaker: Jiarui Zhao, MBBS - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan
• 04:45pm - 06:00pm PT

  Understanding Patient Priorities for Religious and Spiritual Needs during Radiotherapy for Gynecologic Malignancies

  Speaker: Lauren Jacobs, MD - Mount Sinai Hospital, New York
• 04:45pm - 06:00pm PT

  Variation in Treatment Time and On-Board Imaging for Lung Tumors by Motion Management Technique: A Secondary Analysis of the iSABR Trial

  Speaker: John Worth, BS - Stanford University, Palo Alto
• 04:45pm - 06:00pm PT

  Vertebral-Body-Sparing Proton Craniospinal Irradiation in Pediatric Patients: Spinal Growth and Acute Toxicity Outcomes

  Speaker: Chuyu Xia, MD - Peking University First Hospital, Beijing
• 04:45pm - 06:00pm PT

  Voxel-Based Analysis of Cardiac Radiosensitivity: Impact of Consolidation Immunotherapy after Chemoradiotherapy

  Speaker: Hong In Yoon, MD, PhD - Yonsei University College of Medicine, Seoul
• 04:45pm - 06:00pm PT

  ZDHHC15 Mediated <em>S</em>-Palmitoylation of ENO1 Reprograms Glycometabolism to Confer Non-Small Cell Lung Cancer Radioresistance through Upregulating Ku70 and Ku80

  Speaker: Zhiyuan Zhou, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan